Stand 04, Clarion Hotel Helsinki, Tyynenmerenkatu 2, 00220 Helsinki, Finland. Contact us: Lena Kajland Wilén / Director Business Unit Digital Pathology, phone: +46 70 629 07 84 or e-mail:
ContextVision, a medical technology company specializing in image analysis and artificial intelligence, and its research partner HES-SO, Information Systems Institute University of Applied Sciences Western Switzerland, Sierre, presents the first results from the content-based search tool for pathology.
STOCKHOLM – November 8, 2017 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, has added new members to its advisory board for DESUTO, a Eurostar sponsored research program within digital pathology. Professor Junya Fukuoka of the Department of Pathology in Nagasaki and Professor Fredrik Pontén of Uppsala University have both […]
The Centre for Medical Imaging Science and Visualization (CMIV) at Linköping University is developing a new database for medical images and pathology images to offer training data for new artificial intelligence-based (AI) products. As an early partner, ContextVision and one other company, Sectra, will have the opportunity to create commercial value from the database. New, […]
STOCKHOLM – March 29, 2017 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, has started a collaboration and signed an agreement with ALABplus, one of Poland’s largest provider of pathology services, to secure access to a significant amount of data for deep learning product development within digital pathology. “The present […]
STOCKHOLM – Oct. 18, 2016 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, placed top three among automated image analysis in the Tumor Proliferation Assessment Challenge (TUPAC) 2016 competition with its SLDESUTO partner (HES-SO). Many prestigious teams participated, including both highly reputable academic teams and research groups from companies like […]
This important step in ContextVision’s deep learning strategy generates the opportunity for a leading role within digital pathology, a market estimated to be worth $157 million USD by 2018. STOCKHOLM – June 29, 2016 – ContextVision, the leading provider of medical image processing software, has filed a patent for a new method using high-precision deep learning […]
ContextVision AB (OSE: COV), the medical imaging software company, has together with its academic partner been awarded a research grant of € 683,000 for a research program aimed at developing new imaging technology within prostate cancer and digital pathology. The technology under development is expected to expand ContextVision’s market footprint significantly. The research program is […]